Established in 2004, Patient Care America is a licensed specialty pharmacy in all 50 states of the United States. The company is certified and accredited by the International Association of Compounding Pharmacies. This accreditation is recognized nationwide as a symbol of quality that reflects an organization’s commitment to meeting certain performance standards.
Current studies indicate that 10-15% of all patients with Chronic Kidney Disease (CKD) are malnourished. Evidence also indicates that patients with Serum Albumin levels below 3.5 g/dL are at a significant risk of increased morbidity and mortality.
In cases where oral nutrition and supplementation is not enough, a malnourished patient may benefit from IDPN (intradialytic parenteral nutrition) for hemodialysis, or IPN (intraperitoneal nutrition) for peritoneal dialysis. IDPN and IPN are effective therapies for protein replenishment of malnourished patients.
IDPN is the administration of a nutrient solution directly into the bloodstream while a patient is receiving hemodialysis. The solution is made up of amino acids, dextrose, and, when appropriate, lipids to provide both protein and calories in an attempt to meet the patient’s weekly nutritional needs. IDPN therapy is administered at a dialysis clinic.
IPN is the administration of a nutrient solution delivered into the peritoneal cavity. The solution is comprised of amino acids and dextrose which substitutes for a dextrose solution exchange in the patient’s prescribed peritoneal dialysis regimen. The goal of IPN is to provide both protein and calories in an attempt to minimize the patient’s loss of protein through dialysis and meet the patient’s weekly nutritional needs. IPN therapy is typically administered at the patient’s home.